| [1] |
Castro-Manrreza ME, Montesinos JJ. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications[J]. J Immunol Res, 2015, 2015: 394917.
|
| [2] |
Ball LM, Bernardo ME, Roelofs H, et al. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade Ⅲ-Ⅳ acute graft-versus-host disease[J]. Br J Haematol, 2013, 163(4): 501-509.
|
| [3] |
Archambault J, Moreira A, McDaniel D, et al. Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: a systematic review and Meta-analysis of preclinical studies[J]. PLoS One, 2017, 12(12): e0189895.
|
| [4] |
Li W, Zhang Q, Wang M, et al. Macrophages are involved in the protective role of human umbilical cord-derived stromal cells in renal ischemia-reperfusion injury[J]. Stem Cell Res, 2013, 10(3): 405-416.
|
| [5] |
Ben-Mordechai T, Holbova R, Landa-Rouben N, et al.Macrophage subpopulations are essential for infarct repair with and without stem cell therapy[J]. J Am Coll Cardiol, 2013, 62(20): 1890-1901.
|
| [6] |
Panés J, García-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn′s disease: a phase 3 randomised, double-blind controlled trial[J]. Lancet, 2016, 388(10051): 1281-1290.
|
| [7] |
Rocha-Ferreira E, Hristova M. Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage[J]. Front Immunol, 2015, 6(1): 56.
|
| [8] |
Jacobs SE, Morley CJ, Inder TE, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial[J]. Arch Pediatr Adolesc Med, 2011, 165(8): 692-700.
|
| [9] |
Schwerk A, Altschüler J, Roch M, et al. Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning[J]. Cytotherapy, 2015, 17(2): 199-214.
|
| [10] |
Salehi H, Amirpour N, Niapour A, et al. An overview of neural differentiation potential of human adipose derived stem cells[J]. Stem Cell Rev, 2016, 12(1): 26-41.
|
| [11] |
Ma S, Xie N, Li W, et al. Immunobiology of mesenchymal stem cells[J]. Cell Death Differ, 2014, 21(2): 216-225.
|
| [12] |
Peng Y, Chen X, Liu Q, et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5＋ regulatory B cells producing interleukin 10[J]. Leukemia, 2015, 29(3): 636-646.
|
| [13] |
Fu ZW, Zhang ZY, Ge HY. Mesenteric injection of adipose-derived mesenchymal stem cells relieves experimentally-induced colitis in rats by regulating Th17/Treg cell balance[J]. Am J Transl Res, 2018, 10(1): 54-66.
|
| [14] |
Wang Q, Qian S, Li J, et al. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia[J]. Lupus, 2015, 24(11): 1221-1226.
|
| [15] |
Baharlou R, Ahmadi-Vasmehjani A, Faraji F, et al. Human adipose tissue-derived mesenchymal stem cells in rheumatoid arthritis: Regulatory effects on peripheral blood mononuclear cells activation[J]. Int Immunopharmacol, 2017, 47(1): 59-69.
|
| [16] |
Wang Y, Chen XD, Cao W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications[J]. Nat Immunol, 2014, 15(11): 1009-1016.
|
| [17] |
Sudres M, Norol F, Trenado A, et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice[J]. J Immunol, 2006, 176(12): 7761-7767.
|
| [18] |
Polchert D, Sobinsky J, Douglas G, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease[J]. Eur J Immunol, 2008, 38(6): 1745-1755.
|
| [19] |
Waterman RS, Tomchuck SL, Henkle SL, et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype[J]. PLoS One, 2010, 5(4): e10088.
|
| [20] |
Brandau S, Jakob M, Hemeda H, et al. Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge[J]. J Leukoc Biol, 2010, 88(5): 1005-1015.
|
| [21] |
Chatterjee D, Marquardt N, Tufa DM, et al. Human umbilical cord-derived mesenchymal stem cells utilize activin-A to suppress interferon-γ production by natural killer cells[J]. Front Immunol, 2014, 5: 662.
|
| [22] |
Spaggiari GM, Capobianco A, Becchetti S, et al. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation[J]. Blood, 2006, 107(4): 1484-1490.
|
| [23] |
Domenis R, Cifù A, Quaglia S, et al. Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes[J]. Sci Rep, 2018, 8(1): 13325.
|
| [24] |
Murry PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines[J]. Immunity, 2014, 41(1): 14-20.
|
| [25] |
Abumaree MH, Jumah MA, Kalionis B, et al. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages[J]. Stem Cell Rev Report, 2013, 9(5): 620-641.
|
| [26] |
Freytes DO, Kang JW, Marcos-Campos I, et al. Macrophages modulate the viability and growth of human mesenchymal stem cells[J]. J Cell Biochem, 2013, 114(1): 220-229.
|
| [27] |
Cho DI, Kim MR, Jeong HY, et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages[J]. Exp Mol Med, 2014, 46(1): e70.
|
| [28] |
Park HJ, Kim J, Saima FT, et al. Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2[J]. Biochem Biophys Res Commun, 2018, 498(4): 988-995.
|
| [29] |
Holladay CA, Duffy AM, Chen X, et al. Recovery of cardiac function mediated by MSC and interleukin-10 plasmid functionalised scaffold[J]. Biomaterials, 2012, 33(5): 1303-1314.
|
| [30] |
Donega V, Nijboer CH, van Tilborg G, et al. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury[J]. Exp Neurol, 2014, 261(1): 53-64.
|
| [31] |
Jung M, Ma Y, Iyer RP, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation[J]. Basic Res Cardiol, 2017, 112(3): 33.
|
| [32] |
Németh K, Leelahavanichkul A, Yuen PST, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production[J]. Nat Med, 2009, 15(1): 42-49.
|
| [33] |
Ylöstalo JH, Bartosh TJ, Coble K, et al. Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype[J]. Stem Cells, 2012, 30(10): 2283-2296.
|
| [34] |
Yasui M, Tamura Y, Minami M, et al. The prostaglandin E2 receptor EP4 regulates obesity-related inflammation and insulin sensitivity[J]. PLoS One, 2015, 10(8): e0136304.
|
| [35] |
Lee S, Zhang QZ, Karabucak B, et al. DPSCs from inflamed pulp modulate macrophage function via the TNF-α/IDO axis[J]. J Dent Res, 2016, 95(11): 1274-1281.
|
| [36] |
François M, Romieu-Mourez R, Li M, et al. Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation[J]. Mol Ther, 2012, 20(1): 187-195.
|
| [37] |
Corrado C, Raimondo S, Chiesi A, et al. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications[J]. Int J Mol Sci, 2013, 14(3): 5338-5366.
|
| [38] |
Ti DD, Hao HJ, Tong C, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b[J]. J Transl Med, 2015, 13(1): 308.
|
| [39] |
Melief SM, Schrama E, Brugman MH, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages[J]. Stem Cell, 2013, 31(9): 1980-1991.
|
| [40] |
Konala VB, Mamidi MK, Bhonde R, et al. The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration[J]. Cytotherapy, 2016, 18(1): 13-24.
|